MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term

J. Haartsen, T. Spelman, J. Baker, S. Agland, J. Lechner-Scott, T. Burke, S. Vucic, L. Rath, O. Skibina, M. Toubia, M. Slee, B. Taylor, S. Mac Gregor, A. M. Oconnell, M. Barnett, S. Baker, M. Sharma, S. Hodgkinson, S. Walters, A. Kermode & 8 others W. Hayes, E. Butler, N. Sheuy, C. Shaw, R. Portley, T. Hardy, I. L. Tan, H. Butzkueven

    Research output: Contribution to journalAbstract/Meeting Abstract

    22 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)403-404
    Number of pages2
    JournalMultiple Sclerosis Journal
    Volume23
    Publication statusPublished - Oct 2017
    Event7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) - Paris, France
    Duration: 25 Oct 201728 Oct 2017

    Cite this

    Haartsen, J. ; Spelman, T. ; Baker, J. ; Agland, S. ; Lechner-Scott, J. ; Burke, T. ; Vucic, S. ; Rath, L. ; Skibina, O. ; Toubia, M. ; Slee, M. ; Taylor, B. ; Mac Gregor, S. ; Oconnell, A. M. ; Barnett, M. ; Baker, S. ; Sharma, M. ; Hodgkinson, S. ; Walters, S. ; Kermode, A. ; Hayes, W. ; Butler, E. ; Sheuy, N. ; Shaw, C. ; Portley, R. ; Hardy, T. ; Tan, I. L. ; Butzkueven, H. / MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term. In: Multiple Sclerosis Journal. 2017 ; Vol. 23. pp. 403-404.
    @article{9e20f70df45242398aea2c1b5b156194,
    title = "MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term",
    author = "J. Haartsen and T. Spelman and J. Baker and S. Agland and J. Lechner-Scott and T. Burke and S. Vucic and L. Rath and O. Skibina and M. Toubia and M. Slee and B. Taylor and {Mac Gregor}, S. and Oconnell, {A. M.} and M. Barnett and S. Baker and M. Sharma and S. Hodgkinson and S. Walters and A. Kermode and W. Hayes and E. Butler and N. Sheuy and C. Shaw and R. Portley and T. Hardy and Tan, {I. L.} and H. Butzkueven",
    year = "2017",
    month = "10",
    language = "English",
    volume = "23",
    pages = "403--404",
    journal = "Multiple Sclerosis",
    issn = "1352-4585",
    publisher = "SAGE Publications Ltd",

    }

    Haartsen, J, Spelman, T, Baker, J, Agland, S, Lechner-Scott, J, Burke, T, Vucic, S, Rath, L, Skibina, O, Toubia, M, Slee, M, Taylor, B, Mac Gregor, S, Oconnell, AM, Barnett, M, Baker, S, Sharma, M, Hodgkinson, S, Walters, S, Kermode, A, Hayes, W, Butler, E, Sheuy, N, Shaw, C, Portley, R, Hardy, T, Tan, IL & Butzkueven, H 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term' Multiple Sclerosis Journal, vol. 23, pp. 403-404.

    MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term. / Haartsen, J.; Spelman, T.; Baker, J.; Agland, S.; Lechner-Scott, J.; Burke, T.; Vucic, S.; Rath, L.; Skibina, O.; Toubia, M.; Slee, M.; Taylor, B.; Mac Gregor, S.; Oconnell, A. M.; Barnett, M.; Baker, S.; Sharma, M.; Hodgkinson, S.; Walters, S.; Kermode, A.; Hayes, W.; Butler, E.; Sheuy, N.; Shaw, C.; Portley, R.; Hardy, T.; Tan, I. L.; Butzkueven, H.

    In: Multiple Sclerosis Journal, Vol. 23, 10.2017, p. 403-404.

    Research output: Contribution to journalAbstract/Meeting Abstract

    TY - JOUR

    T1 - MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term

    AU - Haartsen, J.

    AU - Spelman, T.

    AU - Baker, J.

    AU - Agland, S.

    AU - Lechner-Scott, J.

    AU - Burke, T.

    AU - Vucic, S.

    AU - Rath, L.

    AU - Skibina, O.

    AU - Toubia, M.

    AU - Slee, M.

    AU - Taylor, B.

    AU - Mac Gregor, S.

    AU - Oconnell, A. M.

    AU - Barnett, M.

    AU - Baker, S.

    AU - Sharma, M.

    AU - Hodgkinson, S.

    AU - Walters, S.

    AU - Kermode, A.

    AU - Hayes, W.

    AU - Butler, E.

    AU - Sheuy, N.

    AU - Shaw, C.

    AU - Portley, R.

    AU - Hardy, T.

    AU - Tan, I. L.

    AU - Butzkueven, H.

    PY - 2017/10

    Y1 - 2017/10

    M3 - Abstract/Meeting Abstract

    VL - 23

    SP - 403

    EP - 404

    JO - Multiple Sclerosis

    JF - Multiple Sclerosis

    SN - 1352-4585

    ER -